The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure

Eur Heart J. 1995 Nov;16(11):1613-8. doi: 10.1093/oxfordjournals.eurheartj.a060785.

Abstract

A number of simple clinical and laboratory variables were analysed in a group of patients with chronic heart failure to evaluate their prognostic significance. Five hundred and fifty-two patients were followed for a maximum of 13 years with a total exposure time to death or censored survival of 1148 years. Of the clinical variables, diuretic dose and NYHA class were related to mortality (P < 0.01), and ischaemic heart disease was associated with a worse prognosis than other aetiologies (P < 0.05). Of the laboratory variables, abnormalities of liver function tests including bilirubin (P < 0.01), aspartate transaminase (P < 0.005), gamma glutamyl transpeptidase (P < 0.005) and alkaline phosphatase (P < 0.01) were all related to mortality as was plasma urate (P < 0.01). Multivariate survival analysis of all variables showed aspartate transaminase (chi 2 17.36, P < 0.001) accounted for the greatest variance followed by serum bilirubin (chi 2 14.35, P < 0.005). Thus, abnormalities in liver function tests have prognostic importance in chronic heart failure.

MeSH terms

  • Aged
  • Cardiac Output, Low / mortality*
  • Cardiac Output, Low / physiopathology*
  • Chronic Disease
  • Cohort Studies
  • Female
  • Humans
  • Liver / physiopathology*
  • Liver Function Tests
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Prognosis
  • Survival Analysis